How gestational diabetes affects fetal growth: monitoring, nutrition and care

After a diagnosis of gestational diabetes, concerns often centre on the baby’s growth and what is still safe to eat. Pregnancy glucose care considers maternal nutrition, glucose and fetal development together. Monitoring helps the maternity and diabetes team adjust food, activity and medication when needed.^4,5

Why glucose regulation changes in pregnancy

Hormonal changes during pregnancy reduce insulin sensitivity, increasing the amount of insulin needed to regulate glucose. Gestational diabetes can develop when insulin secretion does not adequately meet this demand. Genetics, pre-pregnancy metabolic health and body weight also contribute.⁴

Glucose crosses the placenta to supply the fetus. Higher maternal glucose can increase fetal exposure and stimulate fetal insulin secretion, contributing to fat deposition and growth. The large HAPO study found continuous associations between maternal glucose, higher birth weight and higher cord-blood C-peptide, a marker of fetal insulin secretion.³

Large for gestational age, or LGA, generally describes birth weight above the 90th percentile for the relevant gestational reference. Growth is therefore interpreted in relation to gestation and the reference used, with antenatal assessments following development over time.^1,3

These physiological changes explain why pregnancy care attends to the pattern of glucose exposure alongside the baby’s growth. The appropriate plan also needs enough nutrition for the pregnancy.

What treatment can improve

Treatment combines suitable food choices, glucose monitoring, physical activity and medication when needed. Landon and colleagues randomised 958 women with mild gestational diabetes. The treated group had fewer LGA births, shoulder-dystocia events, caesarean deliveries and some pregnancy-related hypertensive outcomes.⁶

This supports integrating glucose management into continuing antenatal care. Bring frequently eaten meals, post-meal readings and practical difficulties to appointments. Repeated breakfast elevations, difficulty eating because of nausea and a work schedule that makes snacks awkward are all useful details to discuss.⁵

Nutrition and fetal development also need follow-up. The team can consider maternal weight change, growth assessments and glucose records together when reviewing the plan.⁵

The aim is to make adjustments that can actually be followed between appointments. Clear instructions on measurement times and when to contact the team make the record more useful.

What recent CGM trials found

GRACE enrolled 375 women with diagnosed gestational diabetes across several European centres. At an average of approximately 29 weeks’ gestation, participants were randomised to real-time CGM or finger-prick monitoring and followed until delivery. Both groups received clinical management.¹

Primary-outcome data were available for 345 participants. LGA occurred in 6 of 170 pregnancies in the CGM group, approximately 4%, and 18 of 175 in the finger-prick group, approximately 10%. Small-for-gestational-age births were approximately 19% and 13%, respectively; that difference was not statistically significant. Dexcom funded the trial.¹

A separate 302-participant study, DipGluMo, used a primary outcome combining several perinatal events and found no significant between-group difference.²

These findings provide specific questions for a clinical discussion about CGM: which periods need more information, what pattern should prompt contact and how the treatment plan would change in response. The trials used different monitoring arrangements and primary outcomes; the study notes preserve those details.

For a pregnant reader, the relevant application is a monitoring plan integrated with the current diagnosis and antenatal care. The clinical team can weigh additional information against device burden, costs and the need for confirmatory checks.

Coordinating food, activity and measurements

Pregnancy requires adequate energy and nutrients. A dietitian can help plan staple portions, protein, vegetables, fruit and snacks around appetite, nausea and glucose responses. Severe food restriction or a large self-directed carbohydrate reduction can compromise nutritional intake and should be discussed with the team.⁵

When food and activity changes do not achieve the prescribed glucose goals, the clinical team may recommend medication. Insulin requirements can change as pregnancy progresses, making regular review and clear records useful.⁵

Pregnant people without a diabetes diagnosis should follow the antenatal screening schedule. Testing commonly occurs at 24–28 weeks, with earlier assessment in some higher-risk situations. Those with pre-existing type 1 or type 2 diabetes require the corresponding specialist care before and during pregnancy.⁴

Practical support matters as well. Discuss access to food, work hours and the ability to attend appointments. A nutritionally adequate plan has to fit the circumstances in which it will be followed.

Follow-up after birth

After delivery, pregnancy-related hormones and insulin requirements change, and the clinical team should review the medication plan. A history of gestational diabetes increases future type 2 diabetes risk, so postpartum testing and subsequent follow-up are important.⁷

NIDDK recommends completing diabetes testing within twelve weeks after birth. The exact timing and test should follow the local maternity team’s arrangements. Confirming the appointment before discharge can make it easier to manage alongside caring for a newborn.⁷

Useful pregnancy care involves several practical steps: adequate food, consistent measurement, planned appointments and knowing whom to contact. Bring the records into a specific conversation with the team so that the next adjustment is clear and manageable.